In addition, TRIM21 was found to be upregulated in monocytes from BD patients and stimulated the NF-κB signaling pathway, leading to the production of monocyte-derived proinflammatory cytokines and the promotion of Th1/Th17-mediated inflammation [28]. This evidence concerns the gene NFKB1 and Behcet disease.